244 related articles for article (PubMed ID: 31888570)
1. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
[TBL] [Abstract][Full Text] [Related]
2. Upregulated NLGN1 predicts poor survival in colorectal cancer.
Yu Q; Wang X; Yang Y; Chi P; Huang J; Qiu S; Zheng X; Chen X
BMC Cancer; 2021 Aug; 21(1):884. PubMed ID: 34340665
[TBL] [Abstract][Full Text] [Related]
3. SPINK4 promotes colorectal cancer cell proliferation and inhibits ferroptosis.
Hu BL; Yin YX; Li KZ; Li SQ; Li Z
BMC Gastroenterol; 2023 Apr; 23(1):104. PubMed ID: 37013514
[TBL] [Abstract][Full Text] [Related]
4. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
5. Association and diagnostic value of serum SPINK4 in colorectal cancer.
Xie M; Li K; Li J; Lu D; Hu B
PeerJ; 2019; 7():e6679. PubMed ID: 30976466
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer.
Xiao S; Yang C; Zhang Y; Lai C
World J Surg Oncol; 2022 Apr; 20(1):110. PubMed ID: 35387659
[TBL] [Abstract][Full Text] [Related]
8. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
10. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
Kwon RJ; Park EJ; Lee SY; Lee Y; Hwang C; Kim C; Cho YH
Lipids Health Dis; 2021 Sep; 20(1):104. PubMed ID: 34511128
[TBL] [Abstract][Full Text] [Related]
12. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
13. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399
[TBL] [Abstract][Full Text] [Related]
14. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of long non-coding RNA SBDSP1 correlates with poor survival in colorectal cancer.
Zhou HB; Li Q; Liu M; Cao YQ; Xu JY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3837-3841. PubMed ID: 28975982
[TBL] [Abstract][Full Text] [Related]
16. Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
Lv Y; Xie B; Bai B; Shan L; Zheng W; Huang X; Zhu H
Oncol Rep; 2019 Dec; 42(6):2473-2485. PubMed ID: 31638246
[TBL] [Abstract][Full Text] [Related]
17. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
[TBL] [Abstract][Full Text] [Related]
18.
Li N; Xiao H; Shen J; Qiao X; Zhang F; Zhang W; Gao Y; Liu YD
J Int Med Res; 2021 Apr; 49(4):3000605211004386. PubMed ID: 33845603
[TBL] [Abstract][Full Text] [Related]
19. Leveraging a KRAS-based signature to predict the prognosis and drug sensitivity of colon cancer and identifying SPINK4 as a new biomarker.
Huo JT; Tuersun A; Yu SY; Zhang YC; Feng WQ; Xu ZQ; Zhao JK; Zong YP; Lu AG
Sci Rep; 2023 Dec; 13(1):22230. PubMed ID: 38097680
[TBL] [Abstract][Full Text] [Related]
20. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
